Unknown PHASE2 INTERVENTIONAL 6-arm NCT02128971

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Sponsor: Albion

Conditions Anemia

Interventions Ferric Glycinate 90 mg Ferrochel® 90 mg Ferrous Sulfate 90 mg Ferrous fumarate 90 mg Placebo Sumalate® 90 mg

Updated 5 times since 2017 Last updated: May 5, 2014 Started: Apr 30, 2014 Primary completion: Jun 30, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Anemia and is currently ongoing. Albion leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Albion
Sprim Advanced Life Sciences

Data source: Albion

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Depok, Indonesia